Composition
- Active ingredients
- PERPHENAZINE 8MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PERPHENAZINE 16MG/5ML · ConcentrateNDA011557-001 · Discontinued
- PERPHENAZINE 5MG/ML · InjectableNDA011213-002 · Discontinued
- PERPHENAZINE 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA010775-003 · Discontinued
- PERPHENAZINE 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA010775-001 · Discontinued
- PERPHENAZINE 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA010775-004 · Discontinued
- PERPHENAZINE 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA010775-002 · Discontinued
- PERPHENAZINE 2MG/5ML · SyrupNDA011294-002 · Discontinued
- PERPHENAZINE 8MG · Tablet, extended releaseThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA011361.
At a glance
- Brand name
- Trilafon
- Active substance
- perphenazine
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Schering
- Status
- Discontinued
- Application
- NDA011361-002